| Prev Close | 377.74 |
| Day Low/High | 374.44 / 380.35 |
| 52 Wk Low/High | 230.31 / 389.50 |
Mastercard Incorporated Class A (MA)
380.08
NYSE
| Exchange | NYSE |
| Shares Outstanding | 993.36B |
| Market Cap | 375.23B |
| P/E Ratio | 49.40 |
| Div & Yield | N.A. (N.A) |
The Week Ahead: Keyed In on Inflation
The CPI report is bound to be in focus this week.
MasterCard on My Radar
The technicals suggest an imminent upward reversal.
Monitise Update
The company could vault into a leadership position in the mobile payments and banking industries. Over the past two weeks, I have participated in several meetings that reinforced my view that Monitise (MONI.L/MONIF) possesses architectural benefits ...
Why Is the Market So Resilient?
The consensus of positives is just too cute.
Don't Commit New Capital
Betting that prices have bottomed off this crisis does seem more than a little glib.
A Peculiar Mix of Action
And a paucity of perky charts.
One Decision to the Next
Looking for a buy trigger on MasterCard.
A Heap of Wealth-Destroying Stupidity
Be sure to ignore any 'World Cup' investment pitches.
Fitz Bits: Do Not Try to Top-Tick
For now, just let the market do the heavy lifting for you.
Tighten Up MasterCard Stops
Also consider the pullback zones for another possible entry.
MasterCard Traces a Playable Zigzag
The daily chart shows a two-step pattern that points to an upside target.
Scanning Future of MasterCard and Visa
Big margins go away when a better mousetrap appears.
Bidding for Monitise
On a scale lower. Monitise (MONI.L/MONIF) is now trading near 60 pence in London. That is more than 10% under the price of the recent private placement purchased by Omega Adivsors, Mastercard (MA) and others. I am bidding on a scale lower.
Adding Quality to the Value Mix
Consider a company's gross profit compared with total assets.
Pfizer's Blockbuster Bid, Yahoo's Laugh Track & Americans Take Off
Pharma giant Pfizer revealed Monday it made a $99 billion bid for AstraZeneca in January and had contacted its rival again on April 26 about a takeover.
I Still Bleed Barron's Blue
This weekend's interview was one of the best and contains some good long-term investing ideas both long and short. My roots run deep with Barron's -- indeed, you might say I bleed Barron's blue. At 15 years of age I began to read Barron's, coinciden...
The Folly of Focusing on Earnings
This is probably the least important number in all of finance.
Buy Your Visa Shares
It's everywhere you want to pay with your phone.
2 Financials Added to My Shopping List
Because a prepared investor is a profitable investor.
Can We Have It Both Ways?
The cheapest segment rallied simultaneously with the most expensive.
The Trader Daily
Monday's primary area of interest on the SPY should be $182.40.
Visa's Prom Spending Numbers Show Double Digit Decline
Prom spending has gone down for the first time since 2010, dropping more than 14% to $978 spent per family in 2014.
Monitise's Price Drop
The big names paid a bit more for the shares during last week's private placement. Mastercard (MA), Omega Advisors et al. paid 68 pence for Monitise (MONI.L) in last week's private placement. This morning, Monitise is trading at 62.50 pence in Londo...
Wal-Mart Sues Visa for $5 Billion Over Credit Card Swipe Fees
Wal-Mart is suing Visa for $5 billion for allegedly conspiring with banks to illegally fix and inflate credit card processing fees.
More Monitise News
Another headline made. Mastercard (MA) and Monitise (MONI.L/MONIF) to partner to deliver digital payment services.
Federal Reserve Debit Card Swipe Fee Upheld, Retailers Disappointed
Retailers were handed a major blow by the Federal Reserve when the appeals court upheld a rule allowing banks to charge retailers as much as twenty-one cents to process debit-card transactions.
Starbucks' Buried Treasure
Its amazing payments system could be worth billions.
